On May 18, Yunkang Group was listed on Hong Kong Exchanges and Clearing Limited (HKEX), stock code: 2325.HK. At press time, it opened down over 10% with a total market capitalisation of approximately HK$4.3 billion.

Recently, Bioeast Biotech announced the completion of the A+ round of financing of RMB 150 million. This round of financing was exclusively invested by LYFE CAPITAL.

University of Notre Dame researchers have discovered another way tumor cells transfer genetic material to other cells in their microenvironment, causing cancer to spread.

The continuous outbreak of the 2021 epidemic has drawn attention to the issue of upstream raw materials in China's IVD industry.

The 2nd China Key Raw Material & Parts Forum (CKRMPF) will be held at Primus Hotel Nanchang International Expo City (Nanchang, China) on October 26 in 2022.

Ever since the first barcode appeared on a pack of chewing gum in 1974, the now-ubiquitous system has enabled manufacturers, retailers and consumers to quickly and effectively identify, characterize, locate and track products and materials.

Medix Biochemica, a global leader in critical IVD raw materials, has acquired all of the shares of Diaclone SAS ("Diaclone"). Through acquisition, Medix Biochemica broadens its portfolio of critical raw materials for the in-vitro diagnostics ("IVD") industry and expands its global network.

On May 16, Mindray Medical announced that it intends to acquire 100% of the equity of HytestInvest Oy in Finland and its subsidiaries.

The 1st China Key Raw Material & Parts Forum, sponsored by China Association of In Vitro Diagnostics (CAIVD), was held in Chongqing Yuelai International Conference Center on March 28, 2021.

The 1st China Key Raw Material & Parts Forum, organized by China Association of In Vitro Diagnostics (CAIVD), is scheduled to be held in Chongqing Yuelai International Convention Center on March 28, 2021.